20/20 Biolabs, Inc.
Ticker: 1139685
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q2 FY26 | Q1 FY26 | Q2 FY25 | Q1 FY25 |
|---|---|---|---|---|
| INCOME | ||||
| Revenue | 0.73+108.6% | 0.35-35.2% | 0.54-1.8% | 0.55 |
| Total Income | 0.73+108.6% | 0.35-35.2% | 0.54-1.8% | 0.55 |
| EXPENSES | ||||
| Expenditure | 1.97+9.4% | 1.80+30.4% | 1.38+3.8% | 1.33 |
| PROFIT | ||||
| Net Profit | -1.51+30.4% | -2.17-158.3% | -0.84-10.5% | -0.76 |
| KEY METRICS | ||||
| OPM % | -100.00% | -100.00% | -100.00% | -100.00% |
| NPM % | -100.00% | -100.00% | -100.00% | -100.00% |
| EPS | -0.26+7.1% | -0.28-64.7% | -0.17-6.3% | -0.16 |